Plan Year Description:

The Plan Year Description is a fundamental term used in the context of employer-sponsored 401(k) retirement plans. It refers to the designated time period during which the plan operates, defining the start and end dates for administrative and compliance purposes. Employers typically set the plan year to coincide with the company's fiscal year or the calendar year. Understanding the Plan Year Description is crucial for participants as it governs key aspects of their 401(k) contributions, vesting schedules, and plan benefits.

Example 1: Suppose Company XYZ's 401(k) plan follows a calendar year plan year description, commencing on January 1st and concluding on December 31st each year. Within this period, employees can make pre-tax contributions to their retirement accounts and may receive employer matching contributions based on the company's policy.

Example 2: Company ABC adopts a non-calendar fiscal year plan year description, running from July 1st to June 30th of the following year. The plan allows employees to enroll or make changes to their investment selections during the open enrollment period that occurs before the start of each plan year.

Example 3: In some cases, employers may implement a short plan year description, like when the 401(k) plan is newly established or terminated. A short plan year typically covers a period less than 12 months and may necessitate specific compliance considerations.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.